Cancer charities have slammed the National Institute for Health and Clinical Excellence's (Nice) decision to reject a drug that prolongs the life of prostate cancer suffers for being too expensive.

Brits would rather insure pets than themselves or their families, a survey has found.

Zurich has revealed it paid 92% of critical illness (CI) claims last year.

Defaqto has released its Star Ratings for private medical insurance (PMI) for the first time.

Government ministers will aim to overturn the exclusion of means-testing of cancer patients receiving Employment and Support Allowance (ESA) as the coalition's government's Welfare Reform Bill moves back to the House of Commons.

Absence management procedures have not kept pace with technology and the way Britain works, resulting in serious welfare, management and productivity issues, a new report has said.

Ellipse has entered the group income protection (GIP) market with the launch of its InteractPlus product which includes an integrated absence management system.

One of the most controversial developments in the protection industry over recent months has been the use of Subject Access Requests (SARs). Russ Whitworth told Owain Thomas a war with doctors may not actually be on the cards

L&G has given the use of Subject Access Requests (SARs) a ringing endorsement and said they produce much better results than other methods of obtaining medical information.

Canada Life has revealed that almost half of its small scheme new business is being done online.